Roflumilast, used in clinics to treat COPD patients, may help to maintain CBF and promote pathogen clearance during airway infections, since such PDE inhibitors are known to prevent PDE-mediated degradation of intracellular cAMP [8]. Here, ALDH7A1 is linked to chronic obstructive pulmonary disease.